A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?
2022
Bleeding, Thrombosis, and Vascular Biology
Preserved Fulltext
For almost 90 years, the discovery and development of anticoagulant drugs have focused on maximizing their antithrombotic efficacy while minimizing the risk of bleeding, in addition to providing manageable compounds with predictable and/or monitorable effects [...].
doi:10.4081/btvb.2022.22
fatcat:a3wi5fxvsrgsxl7jgnn2lrnbeq